
Viral vaccines and viral vectors used in biotherapeutic applications carry the risk of microbial contamination, which must be addressed.
Priyabrata Pattnaik, PHD, is head of biologics operations-Asia Pacific, MilliporeSigma.
Viral vaccines and viral vectors used in biotherapeutic applications carry the risk of microbial contamination, which must be addressed.
Published: September 1st 2018 | Updated: